D.A. Davidson & Co. Scynexis Inc Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Scynexis Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 527,695 shares of SCYX stock, worth $532,971. This represents 0.01% of its overall portfolio holdings.

Number of Shares

527,695

Previous 549,218 3.92%

Holding current value

$532,971

Previous $1.1 Million 28.42%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.27 - $2.23 $27,334 - $47,996	-21,523 Reduced 3.92%	527,695 $786,000
Q2 2024 Jul 31, 2024	BUY	$1.4 - $2.77 $34,651 - $68,560	24,751 Added 4.72%	549,218 $1.1 Million
Q1 2024 May 13, 2024	SELL	$1.39 - $2.21 $2,811 - $4,470	-2,023 Reduced 0.38%	524,467 $770,000
Q4 2023 Feb 09, 2024	BUY	$1.56 - $2.24 $62,655 - $89,967	40,164 Added 8.26%	526,490 $1.17 Million
Q3 2023 Nov 08, 2023	BUY	$1.93 - $3.64 $238,017 - $448,903	123,325 Added 33.97%	486,326 $1.11 Million
Q2 2023 Aug 10, 2023	BUY	$2.38 - $3.67 $138,765 - $213,979	58,305 Added 19.14%	363,001 $1.07 Million
Q1 2023 Apr 25, 2023	BUY	$1.15 - $3.0 $70,229 - $183,207	61,069 Added 25.07%	304,696 $914,000
Q4 2022 Feb 03, 2023	BUY	$1.46 - $2.94 $45,524 - $91,672	31,181 Added 14.68%	243,627 $380,000
Q3 2022 Nov 07, 2022	SELL	$1.83 - $2.93 $70,215 - $112,421	-38,369 Reduced 15.3%	212,446 $510,000
Q2 2022 Jul 28, 2022	SELL	$1.77 - $3.87 $76,154 - $166,506	-43,025 Reduced 14.64%	250,815 $467,000
Q1 2022 May 12, 2022	BUY	$3.56 - $6.66 $20,487 - $38,328	5,755 Added 2.0%	293,840 $1.15 Million
Q4 2021 Jan 31, 2022	BUY	$4.94 - $7.69 $64,788 - $100,854	13,115 Added 4.77%	288,085 $1.76 Million
Q3 2021 Nov 15, 2021	BUY	$5.3 - $7.89 $146,348 - $217,866	27,613 Added 11.16%	274,970 $1.46 Million
Q2 2021 Aug 10, 2021	BUY	$6.5 - $9.97 $188,077 - $288,481	28,935 Added 13.25%	247,357 $1.82 Million
Q1 2021 May 07, 2021	BUY	$6.93 - $9.63 $1.38 Million - $1.91 Million	198,722 Added 1008.74%	218,422 $1.73 Million
Q4 2020 Feb 10, 2021	BUY	$4.28 - $7.87 $4,280 - $7,870	1,000 Added 5.35%	19,700 $151,000
Q3 2020 Nov 02, 2020	BUY	$4.37 - $7.48 $81,719 - $139,876	18,700 New	18,700 $82,000

Others Institutions Holding SCYX

# of Institutions

Shares Held

13.7M

Call Options Held

21.9K

Put Options Held

2.6K

View Full List

About SCYNEXIS INC

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $33M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

More about SCYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account